Sektorale Bewertungen Perspective Therapeutics, Inc.

Aktien

A40EDR

US46489V3024

CATX

Biotechnologie

Realtime-Estimate 16:02:25 31.08.2026 % 5 Tage Veränd. 1. Jan.
3.095 USD -0.48% Intraday Chart für Perspective Therapeutics, Inc. -2.82% +12.73%
Hauptkonkurrenten
KGV (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) Marktkap. / EBITDA (Y) Marktkap. / EBIT (Y) Dividendenrendite (Y) Kap.($)
-3.11x1.5x0.11x578.49x-1.51x-1.53x-.--% 355 Mio.
34.28x4.56x1.32x6.11x18.18x25.57x0.94% 50.47 Mrd.
-21.19x22.09x-0.33x258.61x-22.63x-21.15x-.--% 44.56 Mrd.
33.71x6.16x-35.31x3.27x14.1x21.31x-.--% 43.08 Mrd.
48.04x8.13x0.24x5.57x30.46x35.19x-.--% 41.7 Mrd.
28.96x2.36x0.6x8.75x22.11x26.25x0.4% 33.21 Mrd.
34.16x24.51x2.26x5.6x25.43x26.61x-.--% 16.77 Mrd.
24.12x2.7x0.7x2.1x9.08x14.05x1.12% 14.58 Mrd.
77.98x4.62x-0.34x4.1x15.89x19.52x-.--% 13.92 Mrd.
28.8x1.37x0.28x1.9x11.66x13.28x-.--% 13.12 Mrd.
-44.89x23.49x-38.36x7.57x185.26x-2465.14x-.--% 11.56 Mrd.
52.36x4.57x2.74x8.69x24.65x29.4x0.44% 11.35 Mrd.
40.35x4.64x2.6x4.74x20.5x32.24x0.56% 10.96 Mrd.
-27.46x8.08x1.03x106.91x-30.43x-52.96x-.--% 10.58 Mrd.
-28.95x9.29x-2.76x - -25.57x-25.62x-.--% 10.18 Mrd.
-16.77x706.76x-0.32x10.99x-17.63x-17.01x-.--% 10.15 Mrd.
-30.79x8.87x-7.71x80.26x-20.41x-19.94x-.--% 9.82 Mrd.
-669.67x2.44x6.88x11x65.73x86.54x-.--% 9.77 Mrd.
-24.82x8.57x-8.13x10350.41x-20.44x-20.13x-.--% 9.63 Mrd.
Durchschnitt -24.47x 44.98x -3.92x 636.39x 16.02x -120.71x 0.18% 19.25 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung 0.74x 28.30x -5.15x 323.19x 15.26x -64.62x 0.24%